BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 885 filers reported holding BAXTER INTL INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $39,186 | -25.1% | 1,090,925 | -4.4% | 2.60% | +33.5% |
| Q2 2023 | $52,321 | +12.2% | 1,141,126 | 0.0% | 1.95% | +8.1% |
| Q1 2023 | $46,615 | -14.9% | 1,141,126 | 0.0% | 1.80% | -26.0% |
| Q4 2022 | $54,808 | -99.9% | 1,141,126 | -5.4% | 2.44% | +25.1% |
| Q3 2022 | $65,303,000 | -16.1% | 1,205,957 | 0.0% | 1.95% | -30.5% |
| Q2 2022 | $77,808,000 | -19.2% | 1,205,957 | -2.6% | 2.80% | +14.8% |
| Q1 2022 | $96,310,000 | -9.6% | 1,237,600 | 0.0% | 2.44% | -3.3% |
| Q4 2021 | $106,582,000 | +6.9% | 1,237,600 | +0.2% | 2.52% | +0.1% |
| Q3 2021 | $99,683,000 | -0.1% | 1,235,082 | 0.0% | 2.52% | +15.7% |
| Q2 2021 | $99,770,000 | +1.1% | 1,235,082 | +5.9% | 2.18% | -2.9% |
| Q1 2021 | $98,650,000 | +5.1% | 1,166,281 | 0.0% | 2.24% | -0.3% |
| Q4 2020 | $93,868,000 | -0.5% | 1,166,281 | -0.3% | 2.25% | -9.4% |
| Q3 2020 | $94,369,000 | -6.6% | 1,169,893 | 0.0% | 2.48% | -17.9% |
| Q2 2020 | $101,014,000 | +6.1% | 1,169,893 | 0.0% | 3.02% | -13.4% |
| Q1 2020 | $95,212,000 | +9.1% | 1,169,893 | +12.4% | 3.49% | +22.1% |
| Q4 2019 | $87,239,000 | -1.0% | 1,040,547 | +3.5% | 2.86% | -13.4% |
| Q3 2019 | $88,156,000 | +3.5% | 1,005,318 | -3.1% | 3.30% | +4.7% |
| Q2 2019 | $85,206,000 | +0.7% | 1,037,585 | -0.1% | 3.15% | -8.3% |
| Q1 2019 | $84,653,000 | +28.3% | 1,038,686 | +3.9% | 3.44% | +22.8% |
| Q4 2018 | $65,975,000 | +18.0% | 999,470 | +38.2% | 2.80% | +35.9% |
| Q3 2018 | $55,893,000 | +4.7% | 723,257 | 0.0% | 2.06% | -4.3% |
| Q2 2018 | $53,405,000 | – | 723,257 | – | 2.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |